# AgomAb Therapeutics NV: filings

AGMB · Nasdaq · CIK 2020932 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agmb.md) · [Financials](/companies/agmb/financials.md) · [Filings](/companies/agmb/filings.md) · [Insiders](/companies/agmb/insiders.md)

## Reports and events: 13 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 13, 6-K 11, 4 7, SCHEDULE 13G 4, DRS/A 2, 20-F 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, EFFECT 1, F-1 1, F-1/A 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 21:18 ET | [6-K](/filings/0001104659-26-115567.md) | Report of a foreign private issuer, period 2026-10-13 | 0001104659-26-115567 |
| 2026-10-01 | 10:42 ET | [6-K](/filings/0001104659-26-112564.md) | Report of a foreign private issuer, period 2026-10-01 | 0001104659-26-112564 |
| 2026-09-14 | 20:14 ET | [6-K](/filings/0001104659-26-107500.md) | Report of a foreign private issuer, period 2026-09-14 | 0001104659-26-107500 |
| 2026-09-11 | 21:02 ET | [6-K](/filings/0001104659-26-107117.md) | Report of a foreign private issuer, period 2026-09-11 | 0001104659-26-107117 |
| 2026-08-10 | 20:17 ET | [6-K](/filings/0001104659-26-093390.md) | Report of a foreign private issuer, period 2026-08-10 | 0001104659-26-093390 |
| 2026-08-06 | 20:06 ET | [6-K](/filings/0001104659-26-091992.md) | Report of a foreign private issuer, period 2026-08-06 | 0001104659-26-091992 |
| 2026-06-23 | 20:13 ET | [6-K](/filings/0001104659-26-076819.md) | Report of a foreign private issuer, period 2026-06-23 | 0001104659-26-076819 |
| 2026-05-27 | 11:12 ET | [6-K](/filings/0001104659-26-066590.md) | Report of a foreign private issuer, period 2026-05-27 | 0001104659-26-066590 |
| 2026-04-24 | 20:22 ET | [6-K](/filings/0001104659-26-048615.md) | Report of a foreign private issuer, period 2026-04-24 | 0001104659-26-048615 |
| 2026-04-23 | 21:17 ET | [20-F](/filings/0001104659-26-047872.md) | Annual report of a foreign private issuer, period 2025-12-31 | 0001104659-26-047872 |
| 2026-03-05 | 21:05 ET | [6-K](/filings/0001104659-26-024095.md) | Report of a foreign private issuer, period 2026-03-05 | 0001104659-26-024095 |
| 2026-02-17 | 12:00 ET | [SCHEDULE 13D](/filings/0001193125-26-052946.md) | Ownership report, active investor | 0001193125-26-052946 |
| 2026-02-09 | 21:18 ET | [6-K](/filings/0001104659-26-012080.md) | Report of a foreign private issuer, period 2026-02-09 | 0001104659-26-012080 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.